Dimensional Fund Advisors LP Has $83.89 Million Stake in Certara, Inc. (NASDAQ:CERT)

Dimensional Fund Advisors LP reduced its holdings in Certara, Inc. (NASDAQ:CERT - Free Report) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,877,507 shares of the company's stock after selling 134,401 shares during the period. Dimensional Fund Advisors LP owned 4.89% of Certara worth $83,894,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Venturi Wealth Management LLC increased its position in shares of Certara by 839.1% in the fourth quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company's stock valued at $30,000 after acquiring an additional 2,509 shares during the last quarter. Wells Fargo & Company MN grew its stake in Certara by 48.4% in the fourth quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock valued at $34,000 after purchasing an additional 1,047 shares in the last quarter. Blue Trust Inc. increased its holdings in Certara by 20.9% during the fourth quarter. Blue Trust Inc. now owns 4,747 shares of the company's stock worth $56,000 after buying an additional 822 shares during the last quarter. ANTIPODES PARTNERS Ltd increased its stake in shares of Certara by 204.7% during the 4th quarter. ANTIPODES PARTNERS Ltd now owns 5,442 shares of the company's stock worth $58,000 after purchasing an additional 3,656 shares during the last quarter. Finally, Sterling Capital Management LLC raised its holdings in shares of Certara by 57.2% in the 4th quarter. Sterling Capital Management LLC now owns 7,209 shares of the company's stock valued at $77,000 after purchasing an additional 2,624 shares during the period. 73.96% of the stock is owned by institutional investors.

Certara Price Performance

NASDAQ:CERT opened at $13.89 on Wednesday. Certara, Inc. has a 52 week low of $8.64 and a 52 week high of $17.94. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The firm's 50-day simple moving average is $11.65 and its 200 day simple moving average is $11.61. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -69.45, a P/E/G ratio of 9.29 and a beta of 1.64.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CERT shares. Barclays reduced their price target on Certara from $13.00 to $11.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Stephens reissued an "overweight" rating and set a $17.00 target price on shares of Certara in a report on Thursday, February 27th. TD Cowen started coverage on Certara in a report on Thursday, February 27th. They set a "buy" rating and a $16.00 price target for the company. William Blair reaffirmed a "market perform" rating on shares of Certara in a research report on Thursday, February 27th. Finally, KeyCorp increased their price objective on shares of Certara from $15.00 to $18.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $15.17.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

Want to see what other hedge funds are holding CERT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Certara, Inc. (NASDAQ:CERT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.